Brown & Brown (BRO) Earnings Date & Reports

Key Takeaways

• Total revenues reached $1.68 billion for the second quarter, a 30.4% increase year-over-year, driven largely by the Accession acquisition.
• Adjusted diluted earnings per share (EPS) came in at $1.07, narrowly missing the FactSet consensus estimate of $1.08 by one cent.
• Organic revenue declined 0.7% excluding contingent commissions, though it turned modestly positive at 0.7% when contingent commissions were included.
• Adjusted EBITDAC (Earnings Before Interest, Taxes, Depreciation, Amortization, and Change in Acquisition Earn-Out Payables) rose 27% to $598 million, though the margin contracted 100 basis points to 35.7%.
• The company declared a 10% dividend increase to $0.165 per share and repurchased approximately $500 million in shares over the past six months.
• Management issued an improved second-half outlook, projecting Retail organic growth of 1.5% to 2.5% and Specialty Distribution organic growth of 2% to 4%, excluding contingents.

Earnings Context and Why It Matters

Brown & Brown, one of the largest insurance brokerage firms in the United States, operates across retail brokerage, specialty distribution, and programs. This quarter's results are particularly important because they represent the first full-year comparison that includes the transformative Accession acquisition, which closed in late 2025. Investors are closely watching whether the deal is delivering on its promised scale benefits while also scrutinizing underlying organic trends in a competitive property and casualty insurance market. With catastrophe-property rates declining and commercial pricing remaining mixed, BRO's ability to generate organic growth has become a central question for shareholders evaluating the stock's trajectory.

Reported Results

Brown & Brown reported total revenues of $1.68 billion for the second quarter ended June 30, 2026, reflecting a $391 million increase from the prior-year period. The Accession acquisition contributed approximately $410 million in quarterly revenue, underscoring its significant impact on the top line. However, revenue fell short of the Zacks Consensus Estimate of $1.72 billion, representing a negative surprise of roughly 2.7%.

On the bottom line, GAAP diluted net income per share was $0.84, up 7.7% year-over-year. Adjusted diluted EPS grew 3.9% to $1.07, missing analyst expectations of $1.08. Net income attributable to the company rose 24.7% to $288 million. Adjusted EBITDAC increased 27% to $598 million, though the adjusted EBITDAC margin dipped from 36.7% to 35.7%, partly due to lower interest income compared to the prior-year quarter when the company held elevated cash balances ahead of the Accession closing.

At the segment level, the Retail division delivered total revenue growth of 35.9%, with organic revenue up 2.5% including contingent commissions and 1.5% excluding them. Specialty Distribution saw total revenue grow 28.1%, but organic revenue declined 1.6% including contingents and 3.5% excluding them, weighed down by delayed new-business revenue and continued pressure from declining catastrophe-property insurance rates.

AI Screener

For investors seeking to identify new opportunities or monitor stocks like Brown & Brown in real time, Tickeron's AI Screener offers a powerful AI-driven stock and ETF discovery platform. The tool allows users to scan thousands of equities using customizable filters such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and AI-generated trading signals. Whether you are searching for breakout candidates, tracking earnings-driven momentum, or filtering for specific fundamental criteria, the AI Screener helps streamline research and surface actionable ideas more efficiently than traditional manual screening methods. Explore the screener to see how AI can enhance your market analysis workflow.

Market Reaction and Investor Sentiment

Initial market reaction to Brown & Brown's Q2 results was notably negative, with shares dropping approximately 4.8% in premarket trading following the July 27 release. The modest miss on both revenue and adjusted EPS appeared to trigger the early sell-off. However, sentiment shifted during the regular trading session on July 28, as shares recovered to trade roughly 3% above the prior close. This intraday reversal suggests that investors ultimately focused on management's constructive second-half organic growth guidance and the progress of the Accession integration rather than the headline miss. Year-to-date, BRO shares have underperformed the broader market, down approximately 15% compared to the S&P 500's gain of about 8%, reflecting ongoing nervousness about organic momentum and insurance pricing headwinds.

Forward Outlook and Key Factors to Monitor

Looking ahead, Brown & Brown's second-half guidance provides a clearer roadmap for investors. Management expects Retail organic growth—excluding contingent commissions—to land between 1.5% and 2.5%, while Specialty Distribution is projected to deliver 2% to 4% organic growth on the same basis. The Specialty outlook partly reflects approximately $10 million in delayed new-business revenue from one program that is expected to be substantially recognized in the third quarter.

The company reaffirmed its target of generating $30 million to $40 million in integration synergies during 2026, and management indicated that insurance-market and economic conditions in the second half should remain broadly consistent with recent quarters. This implies continued headwinds in catastrophe-property rates, which are declining 15% to 35%, while primary casualty and professional liability lines remain firmer with rate increases around 5%.

Investors should also monitor the company's evolving artificial intelligence strategy, which now includes partnerships with Anthropic, McKinsey & Company, and Accenture. The initiative aims to improve sales productivity, underwriting efficiency, and client service without requiring incremental technology spending in the near term. Additionally, the company's capital allocation approach—balancing share repurchases, dividend growth, and selective acquisitions—remains a key factor in the total return equation. While management does not anticipate material changes to spending expectations, any acceleration in technology investment or a shift in acquisition strategy could alter the earnings trajectory heading into 2027.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations